From 1999 to 2008, the utilization rate of total knee replacement procedures in the United States more than doubled for the overall population, and tripled for individuals aged 45 to 64 years.
Knee and Hip Pain: Rewarding Optimal Long-Term Management
Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
The American Cancer Society estimated that approximately 1 in 7 men will be diagnosed with prostate cancer during his lifetime.
Comparing Cost and Utilization of 2 Therapies for Metastatic Castration-Resistant Prostate Cancer
Multiple myeloma is a malignant B-cell neoplasm of terminally differentiated plasma cells that accumulate in the bone marrow and frequently invade the adjacent bone, leading to bone destruction and marrow failure.
The Rationale for Comparing the Costs of Competing Treatment Options in Oncology
Let us travel back in time to 2002. “Managed care” had been identified as the source of everything wrong with the healthcare system...
Challenges Surrounding the New Biosimilars Landscape
Diabetes mellitus is a chronic metabolic disorder posing a significant economic burden on the US healthcare system.
Adherence to Antihyperglycemic Treatment Regimen Also Reduces Overall Costs
Opioid-induced constipation (OIC) can be a debilitating side effect of opioid therapy and may result in increased medical costs. The published data on the economic burden of OIC among long-term opioid users are limited.
Opioid-Induced Constipation Associated with Considerable Economic Burden
Pregnancy is associated with a significant cost for employers providing health insurance benefits to their employees. The latest study on the topic was published in 2002, estimating the unintended pregnancy rate for women covered by employer-sponsored insurance benefits to be approximately 29%.
A Call to Action to Address Burden of Unintended Pregnancies in Plans’ Benefit Design
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), the 2 subtypes of pulmonary hypertension, are chronic, debilitating, and life-threatening conditions.
Is It Time for Risk-Sharing Contracts In Specialty Pharmacy?
Page 4 of 12
Results 31 - 40 of 114
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME